Treatment of Diabetic Macular Edema with Intraocular Injection of Dexamethasone

Phase 1

Recruiting

• Conditions: Macular Edema; Diabetes; H360

• Registration Number: RBR-59phz5c
• Lead Sponsor: niversidade Federal de Pernambuco

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-06-28
• Last Update Posted: 26 July 2023
• Study Completion: 2024-07-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

age 18 or older; diagnosis of diabetes mellitus; presence of clinically significant bilateral diabetic macular edema; best corrected visual acuity between 20/400 and 20/40; central macular thickness >= 300 µm, measured by spectral domain optical coherence tomography.

Exclusion Criteria

Any treatment for diabetic macular edema in the past 4 months; Panretinal photocoagulation within the past 4 months; Any eye surgery performed within the past 4 months; History of pars plano vitrectomy; History of open-angle glaucoma or corticosteroid-induced elevated intraocular pressure requiring ocular antiglaucoma or antihypertensive treatment; Intraocular pressure >= 21 mmHg; History of allergy to any product used in the procedure; Presence of tractional retinal detachment

Study & Design

• Study Type: Intervention
• Study Design: Not specified